SCHEMBL3238307

SCHEMBL3238307

COC(CC(=O)CC(OC)OC)OC

nearest known ligand 0.34

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.34
HTT P42858 1/20 0.34
RECQL P46063 1/20 0.34
NPC1 O15118 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TSHR P16473 1/20 0.32
CYP2C19 P33261 1/20 0.31
ALDH1A1 P00352 2/20 0.30
TDP1 Q9NUW8 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11480859 0.89 CYP2C19 (0.45) GAAHTTRECQLNPC1CYP2C19
SCHEMBL2349464 0.86 TDP1 (0.45) GAAHTTRECQLNPC1L3MBTL1
SCHEMBL11600655 0.82 ALDH1A1 (0.39) GAAHTTRECQLTSHRALDH1A1
SCHEMBL10211016 0.82 GAA (0.44) GAAHTTRECQLL3MBTL1TSHR
SCHEMBL2915579 0.82 GAA (0.37) GAAHTTRECQLNPC1L3MBTL1
SCHEMBL3244610 0.80
SCHEMBL28824553 0.80 GAA (0.33) GAAHTTRECQLL3MBTL1
SCHEMBL607414 0.79
SCHEMBL122205 0.79
SCHEMBL16993645 0.78 MCL1 (0.39) CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103123403-A Polarizing film, circular polarizing plate and organic el image display device using the same SUMITOMO CHEMICAL CO 2013-05-29 CN disclosed
CN-103048721-A Polarizing film, circular polarizing plate and method of producing the same SUMITOMO CHEMICAL CO 2013-04-17 CN disclosed
CN-102939327-A Optical film and display device using the same SUMITOMO CHEMICAL CO 2013-02-20 CN disclosed
CN-102879848-A Polarizer and method for manufacturing same SUMITOMO CHEMICAL CORP 2013-01-16 CN disclosed
CN-102863967-A Photoreactive liquid crystal aligning agent, and liquid crystal aligning element and manufacturing method thereof SUMITOMO RUBBER IND 2013-01-09 CN disclosed
US-7745649-B2 Processes for preparing tetrahydropyran-4-one and pyran-4-one UBE INDUSTRIES, LTD. (JP) 2010-06-29 US disclosed
US-20070078272-A1 Processes for preparing tetrahydropyran-4-one and pyran-4-one UBE INDUSTRIES, LTD. (JP) 2007-04-05 US disclosed
EP-1700853-A1 PROCESSES FOR PRODUCING TETRAHYDROPYRAN-4-ONE AND PYRAN-4-ONE Ube Industries, Ltd. (JP) 2006-09-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070078272-A1 Processes for preparing tetrahydropyran-4-one and pyran-4-one ADH1A, ADH1C, ADH5 GAA 4646/4885HTT 2566/4885RECQL 4240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.